All three custom airway splint devices were designed to fit the
anatomy of each child, researchers at the University of Michigan and
colleagues reported in the journal Science Translational Medicine.
The splints were hollow, porous tubes that could be stitched over
the affected airways, forming a scaffolding that helped support the
weakened structures. They were made with a "bioabsorbable" material
known as polycaprolactone that dissolves in the body over time.
Researchers at the University of Michigan made the devices using 3D
printing, in which materials are added in layers to create custom
products. Such printers are already used in medicine to create a
number of custom implants, creating new jaws, hips and hearing
devices, for example.
"This is the first 3-D printed implant specifically designed to
change shape over time to allow for a child's growth before finally
reabsorbing as the disease is cured," said Dr. Glenn Green, an
associate professor of pediatric otolaryngology at C.S. Mott
Children's Hospital at the University of Michigan, and one of the
study's authors.
All three children in the study suffered from tracheobronchomalacia,
a typically fatal condition in which the walls of the trachea and
bronchi are weakened, making them prone to collapse, leading to
respiratory failure and cardiac arrest.
Green said the first child who received the implant three years ago,
a boy named Kaiba Gionfriddo, now appears to be cured of the
disease, and the splint has been absorbed.
Prior efforts to treat these children involved the use of fixed
airway splints that needed to be frequently resized.
[to top of second column] |
"The device worked better than we could have ever imagined," Green
said in a statement.
Prior to the implants, all three children required heavy sedation
and narcotics and the insertion of a breathing tube in their necks
and were on artificial ventilators.
"Now these children are home with their families. Instead of lying
on their backs for weeks, these children are now learning to stand
and run," Green said.
The researchers now plan to study the device further in a larger
clinical trial.
(Reporting by Julie Steenhuysen; Editing by Jonathan Oatis and David
Gregorio)
[© 2015 Thomson Reuters. All rights
reserved.] Copyright 2015 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
|